StockVS

BNB Plus Corp. (BNBX) Analyse boursière

Services Financiers

BNB Plus Corp.

$0.40

+$0.02 (+5.40%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Analyse

Présentation de l'entreprise

BNB Plus Corp. (ticker BNBX) operates within the Financial Services sector, specifically specializing in the Asset Management industry, which implies a focus on the custody, administration, and strategic deployment of capital assets for clients. The company's core business involves providing digital asset treasury services, offering real-time data tracking of treasury performance and market indicators, while also developing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid through its subsidiaries. This operational scope defines its niche at the intersection of financial technology and specialized biotechnological development. Currently, the entity employs 26 individuals to execute these diverse functions. With a market capitalization of $3.54M and annual revenue of $1.83M, BNB Plus Corp. presents itself as a micro-cap entity with a very limited scale. The combination of a modest market cap and relatively low revenue indicates that the company operates with a significantly smaller footprint compared to established large-cap asset managers, suggesting it is in an early stage of commercialization or niche operation.

Santé financière

The financial statements reveal a company generating $1.83M in revenue over the trailing twelve months (TTM) while reporting a net income loss of $-70,157,456 and an EBITDA of $-28,339,856. The substantial disparity between the $1.83M in revenue and the $-70,157,456 net income highlights an extremely aggressive cost structure where expenses vastly outpace income, eroding profitability entirely. Free cash flow stands at $-17,404,216, indicating that the company is burning cash operations and lacks the internal liquidity to fund expansion or debt servicing without external capital infusion. The gross margin is reported at 29.9%, suggesting that the company retains nearly 30% of sales revenue after direct costs, yet this is insufficient to cover overheads. The operating margin is -3248.8%, a figure that underscores severe operational inefficiencies or massive fixed cost burdens relative to sales volume. The profit margin is listed as 0.0%, confirming that the bottom line is in a state of deep deficit. On the balance sheet, the company holds $2.45M in cash against a debt obligation of only $48,861, resulting in a debt-to-equity ratio of 0.27. This configuration suggests a conservative capital structure where cash reserves significantly exceed debt obligations, providing a buffer against liquidity shocks despite the operating losses. The current ratio is 2.32, which indicates a strong ability to meet short-term obligations with current assets. However, the Return on Equity (ROE) of -199.1% and Return on Assets (ROA) of -98.0% reveal that management is currently destroying shareholder value and utilizing assets inefficiently, as both key return metrics are deeply negative.

Évaluation de la valorisation

Valuation metrics for BNBX are heavily influenced by its lack of profitability, as evidenced by a Trailing P/E Ratio (TTM) of 0.00 and a Forward P/E of N/A. The absence of a forward P/E and the zero trailing ratio imply that earnings-based valuation models are not applicable, reflecting the expectation that the company will not generate positive earnings in the near term. The price-to-book ratio is 0.16, indicating that the market values the company at roughly 16% of its book value, which suggests a significant discount relative to the net assets recorded on the balance sheet. The price-to-sales ratio is 1.93, while the EV/EBITDA stands at -0.02; these alternative metrics suggest that the market is pricing the stock based on sales multiples rather than earnings power or enterprise value efficiency due to the negative EBITDA. The stock's price volatility is contextualized by a 52-week high of $24.30 and a 52-week low of $0.61. Given the market cap of $3.54M and the wide trading range, the current valuation sits near the lower end of its historical spectrum relative to the 52-week high, though the exact current price percentage requires real-time data not provided. The Beta is 0.70, which means the stock is less volatile than the broader market, moving with 30% less intensity than the market average.

Growth & Income

The company is experiencing a contraction in top-line growth, with Revenue Growth (YoY) at -35.0% and Earnings Growth (YoY) listed as N/A. The decline in revenue indicates a shrinking market share or a reduction in service demand, while the N/A earnings growth reflects the current inability to calculate growth rates due to negative earnings. Since the company reports a net loss, there are no dividends to distribute, resulting in a Dividend Yield of N/A and a Payout Ratio of 0.0%. Consequently, the company does not pay dividends and theoretically must reinvest any potential future earnings or utilize existing cash reserves to fund operations and research, rather than returning capital to shareholders. The overall growth and income profile is characterized by negative revenue momentum, a complete absence of dividend income, and a reliance on capital markets or cash reserves to sustain operations until profitability is achieved.

Comparaison avec les pairs

BNB Plus Corp. (BNBX) opère dans le secteur Gestion d'Actifs. Voici comment il se compare à ses pairs les plus proches par capitalisation boursière :

Entreprise Ticker Cap. Boursière Ratio P/E
BNB Plus Corp. BNBX $2.88M 0.0
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

Le ratio P/E moyen du secteur Gestion d'Actifs est de 28.6x. BNB Plus Corp. se négocie à un P/E de 0.0.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de BNB Plus Corp.

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

La description de l'entreprise est affichée en anglais.

Visiter le site →

Statistiques Clés

Capitalisation
$2.88M
Ratio P/E
0.00
Plus Haut 52 Sem.
$8.25
Plus Bas 52 Sem.
$0.37
Volume Moyen
874.65K
Bêta
0.56

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NASDAQ
Pays
United States
Employés
26